Skip to main content

ADVERTISEMENT

cardiovascular events

Original Contribution
11/01/2021

Dongliang Fu, MD1; Mengru Liu, MD2; Tong Gao, MD2; Chunyan Li, MD1; Jiangquan Liao, MD1; Mingjing Shao, MM1; Xiang Xiao, MD1; Peng Yang, MMed1; Xianlun Li, MD1; Hong Jiang, MD1

Dongliang Fu, MD1; Mengru Liu, MD2; T...
Dr. Fu and colleagues evaluated MACE and hemorrhagic event rates for an antithrombotic regimen using bivalirudin or UFH during PCI in ACS patients.
Dr. Fu and colleagues evaluated MACE and hemorrhagic event rates for an antithrombotic regimen using bivalirudin or UFH during PCI in ACS patients.
Dr. Fu and colleagues evaluated...
11/01/2021
Journal of Invasive Cardiology